newsfilter
← Latest News
PR Newswire·

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SEATTLE, Dec. 20, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to three new